AMSTERDAM, July 30 2018 — The SkinVision team is thrilled to announce the investment of $US7.6 million in the company to support their journey of bringing convenient, accurate and quick recognition of skin cancer. This funding round has been supported by current shareholders LEO Pharma, PHS Capital and a number of new high net worth impact investors.
“It all started when I got a freckle on my lower back that became a little itchy”, so starts the story of Emma Proctor, a 37-year-old Business Owner from Preston, Lancashire. “I didn’t think much of it at the time, but then one day I realised there was a bit of blood. It was on my lower back in an extremely awkward position to see properly, with a mirror I managed to see that it was looking a little different”.
Copyright © 2021 SkinVision – Skin cancer melanoma detection app.
All Rights Reserved.